Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Acquisitions (2012 - 2023)

Masimo's quarterly Acquisitions came in at -$7.5 million in Q2 2023, down 151.02% quarter-over-quarter from $14.7 million in Q4 2022.

Masimo has reported Acquisitions for 4 years, with the latest figure at -$7.5 million in Q2 2023.

  • For the quarter ending Q2 2023, Acquisitions changed N/A year-over-year to -$7.5 million; the trailing twelve-month figure through Dec 2023 stood at -$7.5 million (down 100.75% YoY), and the FY2023 full-year result was -$7.5 million, down 100.75% from the prior year.
  • Acquisitions for Q2 2023 stood at -$7.5 million, down from $14.7 million in the prior quarter.
  • The five-year high for Acquisitions was $985.5 million in Q3 2022, with the low at -$78.3 million in Q1 2022.
  • Average Acquisitions over 3 years is $141.7 million, with a median of $14.7 million recorded in 2022.
  • Peak annual rise in Acquisitions reached 118.77% in 2022, while the deepest fall reached 118.77% in 2022.
  • Tracing MASI's Acquisitions over 3 years: stood at $31.1 million in 2020, then sank by 52.67% to $14.7 million in 2022, then plunged by 151.02% to -$7.5 million in 2023.
  • The last three Acquisitions figures came in at -$7.5 million (Q2 2023), $14.7 million (Q4 2022), and -$500000.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn -

Historic Data

Download Data 🔒
DateValue
Apr 1, 2023 -7.50 Mn
Dec 31, 2022 14.70 Mn
Oct 1, 2022 -500,000.00
Jul 2, 2022 985.50 Mn
Jan 1, 2022 -78.31 Mn
Jun 27, 2020 31.06 Mn
Mar 28, 2020 47.25 Mn
Sep 29, 2012 30.25 Mn
Jun 30, 2012 -50,000.00
Mar 31, 2012 7.18 Mn